Trexquant Investment LP - REATA PHARMACEUTICALS INC ownership

REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 161 filers reported holding REATA PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 1.49 and the average weighting 0.5%.

Quarter-by-quarter ownership
Trexquant Investment LP ownership history of REATA PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2022$613,349
+199.2%
16,145
+683.7%
0.02%
-10.5%
Q1 2021$205,000
-19.0%
2,060
+0.5%
0.02%
-29.6%
Q4 2020$253,000
-3.4%
2,049
-37.3%
0.03%
+17.4%
Q3 2019$262,000
-54.1%
3,267
-51.1%
0.02%
-43.9%
Q1 2019$571,000
-10.4%
6,682
-41.2%
0.04%
+2.5%
Q4 2018$637,00011,3630.04%
Other shareholders
REATA PHARMACEUTICALS INC shareholders Q2 2019
NameSharesValueWeighting ↓
CPMG Inc 2,896,901$291,457,00032.14%
PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE 46,646$4,693,0005.31%
Ikarian Capital, LLC 471,400$47,423,0003.34%
Duquesne Family Office 695,033$69,927,0002.27%
Camber Capital Management LP 685,000$68,918,0002.12%
LBJ Family Wealth Advisors, Ltd. 30,359$3,054,0001.82%
MADDEN SECURITIES Corp 33,127$3,333,0001.80%
Biondo Investment Advisors, LLC 104,120$10,475,0001.80%
Tolleson Wealth Management, Inc. 60,750$6,112,0001.73%
Keel Point, LLC 97,074$9,767,0001.26%
View complete list of REATA PHARMACEUTICALS INC shareholders